Selected transactions
Region
Outlicensing of the global rights to the Italian range of Dermocosmetics to DermaForce (the Skinbetter Science Division) for an undisclosed double-digit upfront payment, royalties and milestones.
Divestiture to AbbVie-Allergan Aesthetics for an undisclosed purchase price. Transferred brands include Crystalys, HArmonyCa, Hydryalix and Hydryal, Composite Matrix Dermal Fillers based on CAHA.
Exclusive Financial Advisor to Croma in the structuring of the strategic partnership for the manufacturing and supply of Menarini-Relife’s lead dermal filler Range Definisse.
Supply Agreement for two BMG original oral and dental hygiene products: Aftacure Gel and Aftacure Spray.
Exclusive advisor to Vaxon Biotech on a global collaboration partnership, including a call option arrangement an upfront and several clinical performance milestones with a major US oncology player.
Acquisition of global rights to the Belgian Biotech Ablynx’s nanobody technology platform, global licensing agreement across several therapeutic areas.
Completed divestiture of Boehringer Ingelheim’s ectoparasiticides Animal Health Business to Elanco.
Exclusive advisor to BASF AG on the divestment of their global plastic Colorants‘ Business, a transaction involving 11 sites globally and the carve-out of the Headquarters’ support function.